skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

Abstract

Cannabis elicits its mood-enhancing and analgesic effects through the cannabinoid receptor 1 (CB1), a G protein-coupled receptor (GPCR) that signals primarily through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi. Activation of CB1-Gi signaling pathways holds potential for treating a number of neurological disorders and is thus crucial to understand the mechanism of Gi activation by CB1. Here, we present the structure of the CB1-Gi signaling complex bound to the highly potent agonist MDMB-Fubinaca (FUB), a recently emerged illicit synthetic cannabinoid infused in street drugs that have been associated with numerous overdoses and fatalities. The structure illustrates how FUB stabilizes the receptor in an active state to facilitate nucleotide exchange in Gi. Furthermore the results compose the structural framework to explain CB1 activation by different classes of ligands and provide insights into the G protein coupling and selectivity mechanisms adopted by the receptor.

Authors:
 [1];  [1];  [1];  [1];  [1];  [2];  [2];  [1];  [1];  [1];  [3];  [4];  [2];  [1];  [1];  [3]
  1. Stanford Univ. School of Medicine, Stanford, CA (United States)
  2. Stanford Univ. School of Medicine, Stanford, CA (United States); Stanford Univ., Stanford, CA (United States)
  3. Stanford Univ. School of Medicine, Stanford, CA (United States); Stanford Univ., Menlo Park, CA (United States). SLAC National Accelerator Lab
  4. Oregon Health Sciences Univ., Portland, OR (United States)
Publication Date:
Research Org.:
SLAC National Accelerator Lab., Menlo Park, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1503451
Grant/Contract Number:  
AC02-76SF00515; R37DA036246; R01GM083118
Resource Type:
Accepted Manuscript
Journal Name:
Cell
Additional Journal Information:
Journal Volume: 176; Journal Issue: 3; Journal ID: ISSN 0092-8674
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; cannabinoid receptor; CB1; GPCR; cryo-EM; synthetic cannabinoid; Fubinaca; Gi

Citation Formats

Kumar, Kaavya Krishna, Shalev-Benami, Moran, Robertson, Michael J., Hu, Hongli, Banister, Samuel D., Hollingsworth, Scott A., Latorraca, Naomi R., Kato, Hideaki E., Hilger, Daniel, Maeda, Shoji, Weis, William I., Farrens, David L., Dror, Ron O., Malhotra, Sanjay V., Kobilka, Brian K., and Skiniotis, Georgios. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. United States: N. p., 2019. Web. doi:10.1016/j.cell.2018.11.040.
Kumar, Kaavya Krishna, Shalev-Benami, Moran, Robertson, Michael J., Hu, Hongli, Banister, Samuel D., Hollingsworth, Scott A., Latorraca, Naomi R., Kato, Hideaki E., Hilger, Daniel, Maeda, Shoji, Weis, William I., Farrens, David L., Dror, Ron O., Malhotra, Sanjay V., Kobilka, Brian K., & Skiniotis, Georgios. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. United States. doi:https://doi.org/10.1016/j.cell.2018.11.040
Kumar, Kaavya Krishna, Shalev-Benami, Moran, Robertson, Michael J., Hu, Hongli, Banister, Samuel D., Hollingsworth, Scott A., Latorraca, Naomi R., Kato, Hideaki E., Hilger, Daniel, Maeda, Shoji, Weis, William I., Farrens, David L., Dror, Ron O., Malhotra, Sanjay V., Kobilka, Brian K., and Skiniotis, Georgios. Thu . "Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex". United States. doi:https://doi.org/10.1016/j.cell.2018.11.040. https://www.osti.gov/servlets/purl/1503451.
@article{osti_1503451,
title = {Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex},
author = {Kumar, Kaavya Krishna and Shalev-Benami, Moran and Robertson, Michael J. and Hu, Hongli and Banister, Samuel D. and Hollingsworth, Scott A. and Latorraca, Naomi R. and Kato, Hideaki E. and Hilger, Daniel and Maeda, Shoji and Weis, William I. and Farrens, David L. and Dror, Ron O. and Malhotra, Sanjay V. and Kobilka, Brian K. and Skiniotis, Georgios},
abstractNote = {Cannabis elicits its mood-enhancing and analgesic effects through the cannabinoid receptor 1 (CB1), a G protein-coupled receptor (GPCR) that signals primarily through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi. Activation of CB1-Gi signaling pathways holds potential for treating a number of neurological disorders and is thus crucial to understand the mechanism of Gi activation by CB1. Here, we present the structure of the CB1-Gi signaling complex bound to the highly potent agonist MDMB-Fubinaca (FUB), a recently emerged illicit synthetic cannabinoid infused in street drugs that have been associated with numerous overdoses and fatalities. The structure illustrates how FUB stabilizes the receptor in an active state to facilitate nucleotide exchange in Gi. Furthermore the results compose the structural framework to explain CB1 activation by different classes of ligands and provide insights into the G protein coupling and selectivity mechanisms adopted by the receptor.},
doi = {10.1016/j.cell.2018.11.040},
journal = {Cell},
number = 3,
volume = 176,
place = {United States},
year = {2019},
month = {1}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 47 works
Citation information provided by
Web of Science

Save / Share:

Works referencing / citing this record:

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F‐PY‐PICA, 5F‐PY‐PINACA, and their analogs
journal, March 2019

  • Banister, Samuel D.; Kevin, Richard C.; Martin, Lewis
  • Drug Testing and Analysis, Vol. 11, Issue 7
  • DOI: 10.1002/dta.2583

Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine
journal, May 2019

  • Wouters, Elise; Mogler, Lukas; Cannaert, Annelies
  • Drug Testing and Analysis, Vol. 11, Issue 8
  • DOI: 10.1002/dta.2607

Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market
journal, April 2020

  • Norman, Caitlyn; Walker, Gillian; McKirdy, Brian
  • Drug Testing and Analysis, Vol. 12, Issue 4
  • DOI: 10.1002/dta.2767

Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
journal, February 2020


Cryo-EM structure of oxysterol-bound human Smoothened coupled to a heterotrimeric Gi
journal, June 2019


Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
journal, October 2019


Conformational plasticity of the intracellular cavity of GPCR−G-protein complexes leads to G-protein promiscuity and selectivity
journal, May 2019

  • Sandhu, Manbir; Touma, Anja M.; Dysthe, Matthew
  • Proceedings of the National Academy of Sciences
  • DOI: 10.1073/pnas.1820944116

In vitro determination of the efficacy of illicit synthetic cannabinoids at CB 1 receptors
journal, December 2019

  • Sachdev, Shivani; Vemuri, Kiran; Banister, Samuel D.
  • British Journal of Pharmacology, Vol. 176, Issue 24
  • DOI: 10.1111/bph.14829

Molecular Pharmacology of Class F Receptor Activation
journal, October 2019

  • Kozielewicz, Pawel; Turku, Ainoleena; Schulte, Gunnar
  • Molecular Pharmacology, Vol. 97, Issue 2
  • DOI: 10.1124/mol.119.117986

Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
journal, September 2019

  • Rutigliano, Grazia; Bräunig, Julia; Del Grande, Claudia
  • Frontiers in Pharmacology, Vol. 10
  • DOI: 10.3389/fphar.2019.01027

Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
journal, October 2019